Quest Diagnostics (DGX) New Buyout Ramps Up Cancer Diagnosis Quest Diagnostics (DGX) completes the acquisition of PathAI Diagnostics, accelerating the adoption of AI and digital pathology to improve cancer…
Kaum Impulse für die Quest Diagnostics-Aktie (127,3380 €) Wenig Kursbewegung aktuell bei der Aktie von Quest Diagnostics . Der jüngste Kurs betrug 136,84 US-Dollar. Die Wertschätzung der Börsenteilnehmer…
Quest Diagnostics (DGX) Grows in Digital Pathology With New Deal Quest Diagnostics (DGX) pathology laboratories nationwide are set to get a boost with PathAIs AISight digital pathology image management system.…
Quest Diagnostics (DGX) Inks Deal to Acquire PathAI Diagnostics Quest Diagnostics (DGX) latest transaction combines its oncology expertise and scale with PathAIs AI and digital pathology innovations.…
Quest Diagnostics (DGX) Q1 Earnings Top Estimates, Margins Down Quest Diagnostics (DGX) continues its strong momentum of base business revenue growth in the first quarter of 2024.…
Minimale Kursveränderung bei Quest Diagnostics-Aktie (120,7245 €) CODE Das Wertpapier notiert aktuell bei 128,30 US-Dollar. Kaum auffällig ist derzeit an der Börse der Kurs von Quest Diagnostics.…
Quest Diagnostics (DGX) to Post Q1 Earnings: Whats in Store? Acquisitions and partnerships with health plans are expected to drive Quest Diagnostics (DGX) base business performance in the first quarter…
Quest Diagnostics (DGX) Collaborates With Broad Clinical Labs Quest Diagnostics (DGX) collaboration is intended to demonstrate the clinical value of WGS as a first-line genetic test for postnatal…
Quest Diagnostics (DGX) Hurt by Lower Testing Sales, Competition Quest Diagnostics (DGX) faces intense competition, primarily from LabCorp as well as other commercial laboratories and hospitals.…